Orthogem
Nottingham
About Orthogem
Orthogem develops and manufactures synthetic bone grafts. Its patented Tripore technology platform has enabled the creation of a pipeline of SBG's formulated for a variety of clinical applications, ranging from spinal to oral cranial facial surgery. Orthogem's products include TriPore Granules, TriPore MPA, and TriPore Blocks. Wei Lo founded it in 2001, with its headquarters in Nottingham in the United Kingdom.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jun 2017)
- Website: orthogem.com
- Phone: 44-(0)115-950-5721
Industries & Categories
Biotechnology, Clinical Trials, Life Science, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/orthogem-1691688 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.